Labaid Pharmaceuticals Ltd.
- Industry
- Pharmaceutical Manufacturing
- Founded Year
- 2013
- Headquarters
- Dhaka, Bangladesh
- Employee Count
- 400
Key People
- Dr. A.M. Shamim - Founder & Managing Director
- Sakif Shamim - Managing Director & Executive Director
- Raziul Chowdhury - Chief Operating Officer
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with a strong background in the pharmaceutical industry.
Dr. A.M. Shamim, the Founder & Managing Director, has a proven track record in establishing and managing successful healthcare ventures, including Labaid Cardiac Hospital. This experience is indicative of strong leadership capabilities in the MedTech sector.
- Clinical Need
-
Aspect: Very Strong
Summary: The company addresses significant unmet medical needs in Bangladesh.
Labaid Pharmaceuticals Ltd. aims to provide best-in-class medicines to satisfy medical needs, indicating a strong alignment with pressing clinical demands in the region.
- Competition
-
Aspect: Somewhat crowded
Summary: The pharmaceutical market in Bangladesh is competitive but offers growth opportunities.
While the pharmaceutical sector in Bangladesh is competitive, Labaid's focus on innovation and quality positions it to capture market share effectively.
- Technical Challenge
-
Aspect: Predictable
Summary: The company employs advanced manufacturing technologies with manageable technical challenges.
Labaid Pharmaceuticals Ltd. has structured its manufacturing plant with highly developed and technologically advanced facilities to comply with Good Manufacturing Practice (GMP), indicating a predictable technical environment.
- Patent
-
Aspect: Applied
Summary: The company's patent portfolio status is not clearly defined.
Specific information regarding Labaid Pharmaceuticals Ltd.'s patents is not readily available, suggesting a need for further clarification on intellectual property assets.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding from reputable investors.
Labaid Pharmaceuticals Ltd. received an $8.1 million debt financing from the International Finance Corporation in May 2023, indicating robust financial support.
- Regulatory
-
Aspect: 510k/PMA
Summary: The company adheres to international regulatory standards.
Labaid Pharmaceuticals Ltd.'s manufacturing plant is designed to follow world standards like FDA-USA, MHRA-UK, TGA-Australia, and cGMP-WHO, ensuring high regulatory compliance.
Opportunity Rollup
- Odds of Success
- 3.7
- Peak Market Share
- 4.7
- Segment CAGR
- 5.0%
- Market Segment
- Pharmaceutical Manufacturing
- Market Sub Segment
- Generic Pharmaceuticals
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.24 |
| 2 | 0.70 |
| 3 | 1.64 |
| 4 | 3.29 |
| 5 | 4.70 |
Key Takeaway
Labaid Pharmaceuticals Ltd. is well-positioned in the Bangladeshi pharmaceutical market, leveraging strong leadership, advanced facilities, and strategic funding to address significant clinical needs amidst a competitive landscape.